Indirect androgen doping by oestrogen blockade in sports
- 1 June 2008
- journal article
- review article
- Published by Wiley in British Journal of Pharmacology
- Vol. 154 (3), 598-605
- https://doi.org/10.1038/bjp.2008.150
Abstract
Androgens can increase muscular mass and strength and remain the most frequently abused and widely available drugs used in sports doping. Banning the administration of natural or synthetic androgens has led to a variety of strategies to circumvent the ban of the most effective ergogenic agents for power sports. Among these, a variety of indirect androgen doping strategies aiming to produce a sustained rise in endogenous testosterone have been utilized. These include oestrogen blockade by drugs that act as oestrogen receptor antagonists (antioestrogen) or aromatase inhibitors. The physiological and pharmacological basis for the effects of oestrogen blockade in men, but not women, are reviewed.Keywords
This publication has 136 references indexed in Scilit:
- Tolerability, efficacy and pharmacokinetics of bicalutamide 300 mg, 450 mg or 600 mg as monotherapy for patients with locally advanced or metastatic prostate cancer, compared with castrationBJU International, 2006
- The effect of hormone replacement therapy and/or exercise on skeletal muscle attenuation in postmenopausal women: a yearlong interventionClinical Physiology and Functional Imaging, 2005
- Efficacy of tamoxifen and radiotherapy for prevention and treatment of gynaecomastia and breast pain caused by bicalutamide in prostate cancer: a randomised controlled trialThe Lancet Oncology, 2005
- Raloxifene Treatment Is Associated With Increased Serum Estradiol and Decreased Bone Remodeling in Healthy Middle-Aged Men With Low Sex Hormone LevelsJournal of Bone and Mineral Research, 2004
- Double-blind, randomised, multicentre endocrine trial comparing two letrozole doses, in postmenopausal breast cancer patientsEuropean Journal Of Cancer, 1999
- The Effects of Supraphysiologic Doses of Testosterone on Muscle Size and Strength in Normal MenNew England Journal of Medicine, 1996
- Effect of raising endogenous testosterone levels in impotent men with secondary hypogonadism: double blind placebo-controlled trial with clomiphene citrateJournal of Clinical Endocrinology & Metabolism, 1995
- Sex hormone levels in postmenopausal women with advanced metastatic breast cancer treated with CGS 169 49AEuropean Journal Of Cancer, 1994
- Hormonal effects of toremifene in breast cancer patientsJournal of Steroid Biochemistry, 1990
- Induction of Puberty in Men by Long-Term Pulsatile Administration of Low-Dose Gonadotropin-Releasing HormoneNew England Journal of Medicine, 1982